Modern Solutions in the Treatment of HIV: From Antiretroviral Drug Therapy to Human Genome Editing
-
Published:2021-11-16
Issue:
Volume:
Page:159-169
-
ISSN:2456-9119
-
Container-title:Journal of Pharmaceutical Research International
-
language:
-
Short-container-title:JPRI
Author:
Sebaeva Milana Ruslanovna,Gelogaeva Iman Vladimirovna,Suleymanova Naida Ramizovna,Balaeva Kamila Umarovna,Dauletova Aishat Arslanovna,Zakoroeva Zuhra Magomedovna,Kasheshova Saida Hanbertovna,Kozmov Takis Albertovich,Minatulaeva Madina Muslimovna,Maslova Alina Yuryevna
Abstract
The human immunodeficiency virus (HIV) belongs to a group of anthroponotic viral diseases that cause HIV infection in the human body, apotheosely transforming into acquired immunodeficiency syndrome (AIDS). HIV infection, in people without adequate treatment, can lead to serious damage to the immune system (hereinafter referred to as IS), which leads to a sharp decrease in resistance to conditionally pathogenic microbes, as well as to the prevalence of oncological pathologies that may lead to death. Due to its simplicity, convenience, efficiency and cost-effectiveness, CRISPR/Cas has found application in a short period of time in a wide variety of fields of fundamental and applied medicine and biotechnology.
Publisher
Sciencedomain International